Cargando…

Type 2 Diabetes Mellitus and Altered Immune System Leading to Susceptibility to Pathogens, Especially Mycobacterium tuberculosis

There has been an alarming increase in the incidence of Type 2 Diabetes Mellitus (T2DM) worldwide. Uncontrolled T2DM can lead to alterations in the immune system, increasing the risk of susceptibility to infections such as Mycobacterium tuberculosis (M. tb). Altered immune responses could be attribu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferlita, Steve, Yegiazaryan, Aram, Noori, Navid, Lal, Gagandeep, Nguyen, Timothy, To, Kimberly, Venketaraman, Vishwanath
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947370/ https://www.ncbi.nlm.nih.gov/pubmed/31888124 http://dx.doi.org/10.3390/jcm8122219

Ejemplares similares

General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: Mycobacterium avium and Mycobacterium abscessus
por: To, Kimberly, et al.
Publicado: (2020)

Pathogenicity of Type I Interferons in Mycobacterium tuberculosis
por: Mundra, Akaash, et al.
Publicado: (2023)

Review of the Effectiveness of Various Adjuvant Therapies in Treating Mycobacterium tuberculosis
por: Amin, Arman, et al.
Publicado: (2021)

Editorial: Causes for Increased Susceptibility to Mycobacterium tuberculosis – A Close View of the Immune System
por: Venketaraman, Vishwanath
Publicado: (2015)

Cyclic Peptide [R(4)W(4)] in Improving the Ability of First-Line Antibiotics to Inhibit Mycobacterium tuberculosis Inside in vitro Human Granulomas
por: Hernandez, Joshua, et al.
Publicado: (2020)

Effects of Oral Liposomal Glutathione in Altering the Immune Responses Against Mycobacterium tuberculosis and the Mycobacterium bovis BCG Strain in Individuals With Type 2 Diabetes
por: To, Kimberly, et al.
Publicado: (2021)

Mycobacterium tuberculosis
por: Venketaraman, Vishwanath, et al.
Publicado: (2015)

The Effects of Oral Liposomal Glutathione and In Vitro Everolimus in Altering The Immune Responses Against Mycobacterium bovis BCG Strain in Individuals With Type 2 Diabetes
por: To, Kimberly, et al.
Publicado: (2021)

Neutrophils in Mycobacterium tuberculosis
por: Alcantara, Cheldon Ann, et al.
Publicado: (2023)

Investigating the Role of Everolimus in mTOR Inhibition and Autophagy Promotion as a Potential Host-Directed Therapeutic Target in Mycobacterium tuberculosis Infection
por: Cerni, Stephen, et al.
Publicado: (2019)

Effector Mechanisms of Neutrophils within the Innate Immune System in Response to Mycobacterium tuberculosis Infection
por: Warren, Eric, et al.
Publicado: (2017)

Atherosclerosis: pathogenesis and increased occurrence in individuals with HIV and Mycobacterium tuberculosis infection
por: Guilford, Timothy, et al.
Publicado: (2010)

Root Causes of Fungal Coinfections in COVID-19 Infected Patients
por: Amin, Arman, et al.
Publicado: (2021)

Antimycobacterial Effects of Everolimus in a Human Granuloma Model
por: Ashley, David, et al.
Publicado: (2020)

Mycobacterium tuberculosis: Implications of Ageing on Infection and Maintaining Protection in the Elderly
por: Bonavida, Victor, et al.
Publicado: (2022)

A Role of Intracellular Toll-Like Receptors (3, 7, and 9) in Response to Mycobacterium tuberculosis and Co-Infection with HIV
por: Nguyen, Huy, et al.
Publicado: (2020)

Role of B Cells in Mycobacterium Tuberculosis Infection
por: Stewart, Paul, et al.
Publicado: (2023)

Role of Interferons in Mycobacterium tuberculosis Infection
por: Shanmuganathan, Gaithrri, et al.
Publicado: (2022)

Role of NF-κB during Mycobacterium tuberculosis Infection
por: Poladian, Nicole, et al.
Publicado: (2023)

Understanding the Relationship between Glutathione, TGF-β, and Vitamin D in Combating Mycobacterium tuberculosis Infections
por: Singh, Mohkam, et al.
Publicado: (2020)

Everolimus-induced effector mechanism in macrophages and survivability of Erdman, CDC1551 and HN878 strains of Mycobacterium tuberculosis infection
por: Cao, Ruoqiong, et al.
Publicado: (2021)

Flavonoid Mixture Inhibits Mycobacterium tuberculosis Survival and Infectivity
por: Cao, Ruoqiong, et al.
Publicado: (2019)

Mechanisms of Control of Mycobacterium tuberculosis by NK Cells: Role of Glutathione
por: Allen, Michael, et al.
Publicado: (2015)

Effects of Everolimus in Modulating the Host Immune Responses against Mycobacterium tuberculosis Infection
por: Raien, Anmol, et al.
Publicado: (2023)

Glutathione and growth inhibition of Mycobacterium tuberculosis in healthy and HIV infected subjects
por: Venketaraman, Vishwanath, et al.
Publicado: (2006)

An Elucidation of Neutrophil Functions against Mycobacterium tuberculosis Infection
por: Morris, Devin, et al.
Publicado: (2013)

Cutaneous Manifestations of Mycobacterium tuberculosis: A Literature Review
por: Nguyen, Kevin H., et al.
Publicado: (2023)

Glutathione and Adaptive Immune Responses against Mycobacterium tuberculosis Infection in Healthy and HIV Infected Individuals
por: Guerra, Carlos, et al.
Publicado: (2011)

Effects of ReadiSorb L-GSH in Altering Granulomatous Responses against Mycobacterium tuberculosis Infection
por: Islamoglu, Hicret, et al.
Publicado: (2018)

Pathogenesis of Human Immunodeficiency Virus-Mycobacterium tuberculosis Co-Infection
por: Wong, Kevin, et al.
Publicado: (2020)

Effects of Glutathione Diminishment on the Immune Responses against Mycobacterium tuberculosis Infection
por: Cao, Ruoqiong, et al.
Publicado: (2021)

Recent Developments in the Understanding of Immunity, Pathogenesis and Management of COVID-19
por: Yegiazaryan, Aram, et al.
Publicado: (2022)

Liposomal Glutathione Helps to Mitigate Mycobacterium tuberculosis Infection in the Lungs
por: Kachour, Nala, et al.
Publicado: (2022)

Characterization of Dendritic Cell and Regulatory T Cell Functions against Mycobacterium tuberculosis Infection
por: Morris, Devin, et al.
Publicado: (2013)

The Synergistic Effects of the Glutathione Precursor, NAC and First-Line Antibiotics in the Granulomatous Response Against Mycobacterium tuberculosis
por: Teskey, Garrett, et al.
Publicado: (2018)

L-GSH Supplementation in Conjunction With Rifampicin Augments the Treatment Response to Mycobacterium tuberculosis in a Diabetic Mouse Model
por: Beever, Abrianna, et al.
Publicado: (2022)

Exploring Potential COPD Immunosuppression Pathways Causing Increased Susceptibility for MAC Infections among COPD Patients
por: Munjal, Shafaa, et al.
Publicado: (2021)

Potentials of Host-Directed Therapies in Tuberculosis Management
por: Dara, Yash, et al.
Publicado: (2019)

Review of Pediatric Tuberculosis in the Aftermath of COVID-19
por: Rangchaikul, Patrida, et al.
Publicado: (2022)

Pathogenicity and virulence of Mycobacterium tuberculosis
por: Rahlwes, Kathryn C., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9k82v30g2kc9hf1abjpd8j309e